Treatment of patent ductus arteriosus

Seminars in Neonatology

Volumn 8, Issue 6, 2003, Pages 425-432

  Wyllie, Jonathan ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Patent ductus arteriosus; Prevention; Treatment

Indexed keywords

CHLOROTHIAZIDE; ETAMSYLATE; FUROSEMIDE; IBUPROFEN; INDOMETACIN; MAGNESIUM SULFATE; OXYGEN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; SALBUTAMOL; SCAVENGER; STEROID; SURFACTANT; TERBUTALINE;

BABY; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; FETUS DEVELOPMENT; FLUID INTAKE; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HEMODYNAMICS; HUMAN; INCIDENCE; KIDNEY DISEASE; LIQUID; LOW BIRTH WEIGHT; LUNG HEMORRHAGE; MORPHOGENESIS; MORPHOLOGY; NEURODEVELOPMENTAL DISORDER; OXYGEN TENSION; PARENTERAL NUTRITION; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PHOTOTHERAPY; PREGNANCY; PREMATURITY; PROPHYLAXIS; PROTECTION; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; REVIEW; SMOOTH MUSCLE; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; THORACOTOMY; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR PATENCY; VASOCONSTRICTION; VENTILATOR;

EID: 0344010100     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(03)00121-0     Document Type: Article

References (74)

1. Danilowicz D, Rudolph AM, Hoffman JIE. Delayed closure of the ductus arteriosus in premature infants. Pediatrics 1966; 37:74-8.
2. Girling DJ, Halidie-Smith KA. Persistent ductus arteriosus in ill and premature babies. Arch Dis Child 1971;46:177-81.
3. Kitterman JA, Edmunds LH, Gregory GA et al. Patent ductus arteriosus in premature infants: incidence, relation to pulmonary disease and management. N Engl J Med 1972; 287:473-7.
4. Thibeault DW, Emmanouilides GC, Nelson RJ et al. Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants. J Pediatr 1975;86:120-6.
5. Reller MD, Zeigler ML, Rice MJ et al. Duration of ductal shunting in healthy preterm infants: an echocardiographic color flow Doppler study. J Pediatr 1988;112:441-6.
6. Evans JU, Archer LNJ. Postnatal circulatory adaptation in healthy term and preterm neonates. Arch Dis Child 1990; 65:24-6.
7. Jones RWA, Pickering D. Persistent ductus arteriosus complicating respiratory distress syndrome. Arch Dis Child 1977; 52:274-81.
8. Hornblad PY. Embryological observations of the ductus arteriosus in the guinea pig, rabbit, rat and mouse. Studies on the closure of the ductus. Acta Physiol Scand 1969; 76:49-57.
9. Heyman MA, Rudolph AM. Control of the ductus arteriosus. Physiol Rev 1975;55:62-78.
10. Olley PM, Coceani F. Lipid mediators in the control of the ductus arteriosus. Am Rev Respir Dis 1987;136:219.
11. Clyman RI. Ductus arteriosus: current theories of prenatal and postnatal regulation. Semin Perinatol 1980; 4:115-24.
12. Coceani F, Olley PM. The control of cardiovascular shunts in the fetal and neonatal period. Can J Physiol Pharmacol 1988;66:1129-34.
13. Gittenberger-de Groot AC, Van Ertbruggen I, Moulaert AJMG et al. The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr 1980;96:88-93.
14. Hiraishi S, Misawa H, Oguchi K. Two-dimensional Doppler echocardiographic assessment of closure of the ductus arteriosus in normal newborn infants. J Pediatr 1987; 111:755-60.
15. Daniels O, Hopman JCW, Stoelinga GBA et al. Doppler flow characteristics in the main pulmonary artery and the LA/AO ratio before and after ductal closure in healthy newborns. Pediatr Cardiol 1982;3:99-104.
16. Gentile R, Stevenson G, Dooley T et al. Pulsed Doppler ecocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr 1981;98:443-8.
17. Ellison RC, Peckham GJ, Lang P et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983;71:364-72.
18. Milne MJ, Sung RYT, Fok TF et al. Doppler echocardiographic assessment of shunting via the ductus arteriosus in newborn infants. Am J Cardiol 1989;64:102-5.
19. Reller MD, Zeigler ML, Rice MJ et al. Duration of ductal shunt in healthy preterm infants: an echocardiographic color flow Doppler study. J Pediatr 1989;112:441-6.
20. Moss AJ, Emmanoulides GC, Adams FH et al. Response of the ductus arteriosus and pulmonary and systemic arterial pressure to changes in oxygen environment in newborn infants. Pediatrics 1964;33:937-44.
21. Clyman RI, Mauray F, Wong L et al. The developmental response of the ductus arteriosus to oxygen. Biol Neonate 1978;34:177-81.
22. Clyman RI, Mauray F, Rudolph AM et al. Age dependent sensitivity of the lamb ductus arteriosus to indomethacin and prostaglandins. J Pediatr 1980;96:94-8.
23. Clyman RI, Campbell D, Heymann MA et al. Persistent responsiveness of the neonatal ductus arteriosus in immature lambs: a possible cause for reopening of the patent ductus arteriosus after indomethacin-induced closure. Circulation 1985;71:141-5.
24. Clyman RI, Saugstad OD, Mauray F. Oxygen metabolites stimulate prostaglandin E-2 production and relaxation of the ductus arteriosus. Clin Res 1988;36:228A.
25. Clyman RI, Ballard PL, Sniderman S et al. Prenatal administration of betamethasone for prevention of ductus arteriosus. J Pediatr 1981;98:123-6.
26. Waffern F, Siassi B, Cabal LA et al. Effect of antenatal glucocorticoids on clinical closure of the ductus arteriosus. Am J Dis Child 1983;137:336-8.
27. Morales WJ, Angel JL, O'Brien WF et al. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomised controlled study. Obstet Gynecol 1989; 73:721-6.
28. Papanicolaou N, Safar M, Hornych A et al. The release of renal prostasglandins during saline infusion in normal and hypertensive subjects. Clin Sci Mol Med 1975; 49:459-63.
29. Bell EF, Warburton D, Stonestreet BS et al. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 1980;302:598-604.
30. Lorenz JM, Kleinamn LI, Kotagal UR et al. Water balance in very Low-birthweight infants: relationship to water and sodium intake and effect on outcome. J Pediatr 1982; 101:423-32.
31. Clyman RI, Rudolph AM. Patent ductus arteriosus: a new light on an old problem. Pediatr Res 1978;12:92-4.
32. Rosenfeld W, Sadhev S, Burnot V et al. Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding. Pediatrics 1986; 78:10-4.
33. Raju TNK, Bhat R, McCulloch KM et al. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyatine membrane disease. Lancet 1987;1:651-6.
34. Soll RF, McQueen MC. Respiratory distress syndrome. In: Sinclair JC, Bracken MB, editors. Effective care of the newborn infant. Oxford: Oxford University Press, 1992;325-68.
35. McGrath RL, McGuiness GA, Way GL et al. The silent ductus arteriosus. J Pediatr 1978;93:110-3.
36. Archer LNJ, Glas EJ, Godman MJ. The silent ductus arteriosus in idiopathic respiratory distress syndrome. Acta Paediatr Scand 1984;73:652-6.
37. Archer N. Patent ductus arteriosus in the newborn. Arch Dis Child 1993;69:529-32.
38. Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for ductus arteriosus. J Paediatr Child Health 1994; 30:406-11.
39. Skinner JR, Hunter S, Hey EN. Cardiorespiratory collapse and the silent ductus. Klin Padiatr 1991;203:52.
40. Skinner J. Ductal shunting. In: Skinner J, Alverson D, Hunter S, editors. Echocardiography for the neonatologist. London: Churchill Livingstone, 2000;151-67.
41. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995; 127:774-9.
42. Iyer P, Evans N. Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child 1994;70:F112-7.
43. Walther F, Kim D, Ebrahimi M et al. Pulsed Doppler measurement of the left ventricular output as an early predictor of symptomatic patent ductus arteriosus in very preterm infants. Biol Neonate 1989;56:121-8.
44. Skinner JR, Hunter S, Hey EN. A new method to assess ductal shunting. Paediatr Rev Commun 1991;6:58-9.
45. Evans N. Diagnosis of patent ductus arteriosus in the preterm newborn. Arch Dis Child 1993;68:58-61.
46. Belik J, Spitzer AR, Clark BJ et al. Effect of early furosemide administration in neonates with respiratory distress syndrome. Pediatr Pulmonol 1987;3:219-25.
47. Yeh TF, Shibli A, Leu ST et al. Early furosemide therapy in premature infants (<2000gm) with respiratory distress syndrome: a randomized controlled trial. J Pediatr 1984; 105:603-9.
48. Benson JWT, Hayward C, Osborne JP et al. Multicentre trial of ethamsylate for prevention of periventricular hemorrhage in very low birthweight infants. Lancet 1986; 2:1297-300.
49. Cassady G, Grouse DT, Kirklin JW et al. A randomized trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000g or less at birth. N Engl J Med 1989;320:1511-6.
50. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants (Cochrane review). The Cochrane library, issue 1. Oxford: Update Software, 2003.
51. Schmidt B, Davis P, Moddemann D et al.the TIPP investigators Long-term effects of indomethacin prophylaxis in extremely-low birth weight infants. N Engl J Med 2001; 344:1966-72.
52. Patel J, Marks KA, Roberts I et al. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995;346:255.
53. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birthweight infants (Cochrane review). The Cochrane library, issue 2. Oxford: Update Software, 2003.
54. Archer N. Drug induced closure of the patent ductus artiosus. Heart 1996;76:384-5.
55. Sniderman S, Chung M, Roth R, Ballard R. Treatment of chronic lung disease with furosemide. Clin Res 1978; 26:201.
56. Engelhardt B, Elliot S, Hazinski TA. Short and long term effects of furosemide on lung function in infants with bronchopulmonary dysplasia. J Pediatr 1986;109:1034-9.
57. Gersony WM, Peckham GJ, Ellison RC et al. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906.
58. Peckham GJ, Miettinen OS, Ellison RC et al. Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomised trial of indomethacin. J Pediatr 1984;105:285-91.
59. Hammerman C, Aramburo MJ. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr 1990;117:771-6.
60. Rennie JM, Cooke RWI. Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child 1991;66:55-8.
61. Indomethacin. Neonatal formulary. The northern neonatal network Oxford: BMJ Publishing Group, 1996.
62. Yeh TF, Wilks A, Singh J et al. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. J Pediatr 1982; 101:433-7.
63. Evans DH, Levene MI, Archer LNJ. The effect of indomethacin on cerebral blood flow velocity in premature infants. Dev Med Child Neurol 1987;29:776-82.
64. Coombs P, Morgan MEI, Durbin GM et al. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parental indomethacin. Arch Dis Child 1990; 65:1067-71.
65. Edwards AD, Wyatt JS, Richardson C et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335:1491-5.
66. Fujii AM, Brown E, Mirochnick M et al. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. J Perinatol 2002;22:535-40.
67. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birthweight infants (Cochrane review). The Cochrane library, issue 2. Oxford: Update Software, 2003.
68. Kumar RK, Yu VY. Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants. J Paediatr Child Health 1997;33:38-41.
69. Cotton RB, Stahlman MT, Bender HW et al. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm babies. J Pediatr 1978;93:647-51.
70. Daniels SR, Reller MD, Kaplan S. Recurrence of patency of the ductus arteriosus after surgical ligation in premature infants. Pediatrics 1984;73:74-8.
71. Mavroudis C, Backer CL, Gevitz M. Forty-six years of patent ductus arteriosus division at Children's Memorial Hospital of Chicago. Standards for comparison. Ann Surg 1995; 220:402-9.
72. Mortier E, Ongenae M, Vermassen F et al. Operative closure of patent ductus arteriosus in the neonatal intensive care unit. Acta Chir Belg 1996;96:266-8.
73. Hines MH, Bensky AS, Hammon JW Jr et al. Video-assisted thoracoscopic ligation of patent ductus arteriosus: safe and outpatient. Ann Thorac Surg 1998;66:853-8.
74. Forster R. Thoracoscopic clipping of patent ductus arteriosus in premature infants. Ann Thorac Surg 1993; 56:1418-20.